Protocol
The Synaxis Core 90-Day Protocol
When Omega-3 intake isn't effective
Doesn't fully respond to what's being fed
Varies more than expected between sessions
Feel inconsistent under load
Persists despite careful management
What Omega-3 (DHA and EPA) do
DHA and EPA are incorporated into cell membranes throughout the body. Once incorporated, they influence how tissues respond to stress — particularly in inflammatory signalling.
Their effects show up where membrane function matters most — recovery, joints,
respiratory function, and skin.
This is why changes don’t appear instantly — they reflect structural incorporation over time.
Read more about how this worksWhat the Protocol is and isn’t
A note on research
In a randomised controlled trial, algae-derived DHA supplementation increased plasma DHA levels and was associated with measurable changes in airway inflammatory markers in horses.
What to expect over 90 days
What happens after 90 days
If you've seen no change, stop. Don't continue. We'll be in touch at the end of the protocol — tell us honestly what you observed.
If you've seen benefit, the biology tells you what to do next. DHA and EPA are not stored in large reserves. If supplementation stops, the gains made over 90 days will gradually reverse. A monthly subscription maintains what the protocol established at the lowest per-bottle cost.
If you've seen benefit but want to manage cost, pausing over summer and supplementing through winter is a reasonable approach. Horses on good-quality summer grass are getting some omega-3 from forage — enough to shift the baseline, though not a direct replacement for EPA and DHA. When hay becomes the primary roughage source, the case for supplementing returns.
If you pause and restart the following autumn, treat it as a new protocol. Don't assume residual benefit carries over.
Start the 90 Day Protocol
- Formulation informed by published veterinary research
- Algae-derived EPA and DHA — no conversion required
- Three ingredients, nothing undisclosed
- UK registered company — Synaxis Ltd, No. 17137114